MetLife director awarded 587 shares in stock grant

Glaser Daniel S reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Glaser Daniel S reported acquisition or exercise transactions in this Form 4 filing.

MetLife Inc. director Daniel S. Glaser reported a stock-based compensation award of 587 shares of MetLife common stock, valued at $87.40 per share. This award is part of non-management director retainer fees that are paid in MetLife common stock.

After this grant, Glaser directly holds 2,695 MetLife common shares. He also has an additional 198 shares held indirectly through a grantor retained annuity trust (GRAT). The director elected to defer receipt of the awarded shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Insider Trade Summary

Grant/Award: 587 shares

Grant/Award 2 txns

Insider Glaser Daniel S

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	587	$87.40	$51K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 2,695 shares (Direct); Common Stock — 198 shares (Indirect, By GRAT)

Footnotes (2)

1. F1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
2. F2. These shares are held in a GRAT.

Key Figures

Stock grant size: 587 shares Grant price: $87.40 per share Direct holdings after grant: 2,695 shares +1 more

4 metrics

Stock grant size 587 shares Common stock grant/award to director on June 16, 2026

Grant price $87.40 per share Value per share for the 587-share common stock award

Direct holdings after grant 2,695 shares MetLife common stock directly held by Glaser following the award

Indirect GRAT holdings 198 shares MetLife common stock held indirectly in a GRAT

Key Terms

Grant, award, or other acquisition, MetLife Deferred Compensation Plan for Non-Management Directors, GRAT

3 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

MetLife Deferred Compensation Plan for Non-Management Directors financial

"The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."

GRAT financial

"These shares are held in a GRAT."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did MetLife (MET) director Daniel S. Glaser report in this Form 4?

Daniel S. Glaser reported receiving 587 shares of MetLife common stock as part of non-management director compensation. These shares are treated as stock-based retainer fees and increase his direct holdings to 2,695 MetLife shares after the reported grant.

What is the size and price of the MetLife (MET) stock award to Daniel S. Glaser?

The reported stock award to Daniel S. Glaser was 587 shares of MetLife common stock at $87.40 per share. This reflects non-management director retainer fees that are paid in MetLife stock rather than cash under the company’s compensation arrangements.

How many MetLife (MET) shares does Daniel S. Glaser hold after this Form 4?

Following the reported grant, Daniel S. Glaser directly holds 2,695 MetLife common shares. In addition, 198 MetLife shares are held indirectly in a grantor retained annuity trust (GRAT), as disclosed, giving a fuller picture of his reported equity exposure.

Is the MetLife (MET) stock reported by Daniel S. Glaser a purchase or compensation award?

The filing characterizes the 587 MetLife shares as a grant or award, not an open-market purchase. Footnotes explain that MetLife’s non-management director compensation pays part of retainers in common stock, which Glaser elected to defer under the deferred compensation plan.

What is the role of the GRAT mentioned in Daniel S. Glaser’s MetLife (MET) holdings?

The filing notes that 198 MetLife common shares are held in a grantor retained annuity trust (GRAT). This indicates those particular shares are held indirectly, separate from the 2,695 shares Glaser holds directly after the reported stock-based compensation grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 04:11 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glaser Daniel S

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/16/2026		A(1)		587	A	$87.4	2,695	D
Common Stock								198(2)	I	By GRAT

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

2. These shares are held in a GRAT.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)